Pharmacist Immunization Podcast 30m

Respiratory syncytial virus (RSV) continues to pose a serious health threat—particularly to infants, older adults, and immunocompromised individuals—making it critical for pharmacy professionals to stay up to date on prevention and treatment options. This episode covers the latest FDA-approved RSV therapies, including vaccines and monoclonal antibodies, while highlighting clinical pearls for use across care settings. Tune in to stay informed and better support patients during the upcoming respiratory season. 

Learning Objectives

Upon successful completion of this course, pharmacists should be able to:
1. Differentiate between RSV vaccines and monoclonal antibody therapies, including their indications and target patient populations.
2. Identify key counseling points and administration considerations associated with currently available RSV vaccines and monoclonal antibody therapies.

Faculty

Joshua Davis Kinsey, PharmD

VP, Education
CEimpact

Disclosures:

Joshua Davis Kinsey has no relevant financial relationships with ineligible companies to disclose.

Kalen Manasco, PharmD, BCPS, BCPPS, FCCP, FPPA

Professor
University of Florida College of Pharmacy

Disclosures:

Kalen Manasco has no relevant financial relationships with ineligible companies to disclose.

Course Details